chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.2
Sex: F
Vaccine: RV5
Symptoms: Vomiting projectile
Clinical narrative: Information has been received from a health professional concerning an 11 week old female who on 09-MAR-2007, at 11:30 a.m., was vaccinated with a first oral dose of Rotateq (Lot # 656189/1239F). There was on illness at the time of vaccination. On 09-MAR-2007 immediately after receiving the vaccination, at "11:00 a.m., the patient experienced projectile vomiting. It was noted that the physician may not complete the vaccination series. There were no laboratory or diagnostic tests performed. Medical attention was not sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 0.3
Sex: M
Vaccine: RV5
Symptoms: Abnormal faeces, Culture, Diarrhoea, Pyrexia, Vomiting
Clinical narrative: Information has been received from a physician concerning a 20 week old male who on 07-FEB-2007 was vaccinated with a second dose of Rotateq. Approximately three weeks later, on 27-FEB-2007, the patient experienced three days of severe diarrhea and fever. Subsequently, on 12-MAR-2007 and 13-MAR-2007, the patient's mother brought the patient to the office because the child was experiencing fever, vomiting, and diarrhea. Also the patient's "stool was very foul smelling." Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 0.16
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Vomiting
Clinical narrative: Information has been received from a physician concerning a 10 week old female who, "in mid February," on approximately 14-FEB-2007, was vaccinated with an oral 2 ml dose of Rotateq. Concomitant vaccines included a dose of Comvax, a dose of Prevnar and a dose of  DTaP. After the vaccination with Rotateq the patient threw up three times. There was no blood in the vomit. The patient recovered 24 hours after receiving the vaccine. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested. 08/31/07 This is in follow-up to report(s) previously submitted on 4/13/2007. Information has been received from a physician concerning an 8 week old female, with no medical history and no allergies, who on 05-MAR-2007, at 5:00 p.m., was vaccinated with an oral 2 ml first dose of ROTATEQ (Lot# 654247/0600F). Concomitant vaccines administered at the same time included a dose of COMVAX (OMPC) (MSD) (Lot# 654908/0999F), a dose of PREVNAR, a first subcutaneous dose in the left of IPOL (Lot# Z02400) and a first dose in the left upper leg of TRIPEDIA (Lot# C2650AD). There was no illness at the time of vaccination and no adverse events following prior vaccination. After the vaccination, on 05-MAR-2007, at approximately 7:00 p.m., with ROTATEQ the patient threw up three times. There was no blood in the vomit. The patient recovered 24 hours after receiving the vaccine. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Sex: M
Vaccine: RV5
Symptoms: Diarrhoea, Lethargy
Clinical narrative: Information has been received from a health professional concerning a male who was vaccinated PO with a first dose of Rotateq. Subsequently the patient experienced diarrhea for seven days. The patient was also reported as being lethargic. Unspecified medical attention was sought. Subsequently, the patient recovered. Additional information has been requested.
Age: 0.17
Sex: F
Vaccine: RV5
Symptoms: Diarrhoea
Clinical narrative: Information has been received from a physician concerning a 2 month old female, with no medical history and no allergies, who was vaccinated with an oral first dose of Rotateq. There was no concomitant medication. Two days later receiving Rotateq the patient developed mild diarrhea that lasted for about one day. The patient had since been administered her second dose, at 4 months of age, of Rotateq and did not develop any diarrhea. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. NO product quality complaint was involved. Additional information has been requested.
Age: 0.3
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Rotavirus infection, Rotavirus test positive
Clinical narrative: Information has been received from a nurse concerning a male who on 29-JAN-2007 was vaccinated PO with the second 2.0 mL dose of Rotateq (1st dose given on unknown date). The nurse reported that on 13-MAR-2007, the patient developed rotavirus. Unspecified medical attention was sought and laboratory test were performed (tests and results not provided). At the time of this report, the outcome was unknown. Additional information has been requested. This is in follow-up to report (s) previously submitted on 4/13/2007.  Information has been received from a nurse concerning a 4-month-old male with no medical history who on 29-JAN-2007, at 1500, was vaccinated PO with the second 2.0 mL dose of ROTATEQ (Lot # 652964/0145F) (1st dose given on unknown date).  Concomitant vaccination administered on that same day and time included the second dose in the left vastus lateralis of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (Lot #C2490AA), the second dose in the right vastus lateralis of Hib conj vaccine (OMPC) (MSD) (Lot #654072/1013F), the second dose in the right vastus lateralis of PREVNAR (Lot #B086468) and a SC dose of IPOL (Lot #Y1050).  There was no illness at the time of vaccination.  The nurse reported that on 13-MAR-2007, the patient developed rotavirus.  Unspecified medical attention was sought.  A rotavirus test was positive.  At the time of this report, the outcome was unknown.  Additional information has been requested.
Age: 0.17
Sex: M
Vaccine: RV5
Symptoms: Diarrhoea, Gastroenteritis rotavirus
Clinical narrative: Information has been received from a registered nurse (RN) concerning an approximately 15-week-old male with asthma and not drug allergies who on 16-JAN-2007 was vaccinated PO with the first 2.0 mL dose of Rotateq (Lot #655407/1115F). Concomitant therapy included PULMICORT and albuterol. The RN reported that on approximately 02-MAR-2007, the patient possibly developed rotavirus. Unspecified medical attention was ought, but no laboratory/diagnostic test were performed. At the time of this report, the patient was noted to be recovering. Additional information has been requested. 08/31/07 This is in follow-up to report(s) previously submitted on 4/13/2007. Information has been received from a registered nurse (RN) concerning a 14-week-old male with asthma and no drug allergies who on 16-JAN-2007, at 1000, was vaccinated PO with the first 2.0 mL dose of ROTATEQ (Lot #655407/1115F). Illness at the time of vaccination included RSV bronchiolitis. Concomitant therapy included PULMICORT and albuterol. The RN reported that on the morning of 27-FEB-2007 (previously reported as appoximately 02-MAR-2007), the patient developed foul-smelling, watery, green diarrhea (previously reported as rotavirus). Unspecified medical attention was sought, but no laboratory/diagnostic tests were performed to determine whether the symptoms were related to rotavirus. On 13-MAR-2007, the patient recovered without medical treatment. Follow-up care was not necessary. It was advised to "feed through diarrhea". Additional information is not expected.
Age: 0.25
Sex: M
Vaccine: RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 13-week-old male who was vaccinated with the first dose of Rotateq. It was unknown if medical attention was sought. Additional information has been requested.
Age: 0.17
Sex: F
Vaccine: RV5
Symptoms: Diarrhoea, Gastroenteritis rotavirus, Vomiting
Clinical narrative: Information has been received from physician concerning an 8-week-old female who on 16-MAR-2007 was vaccinated with a dose of Rotateq. The physician reported that on 18-MAR-2007, the patient developed vaccine induced rotavirus characterized by vomiting along with diarrhea which started on the morning 19-MAR-2007. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 0.47
Sex: M
Vaccine: RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 24-week-old male who on 20-MAR-2007 was vaccinated with the second dose of Rotateq (1st dose administered on 07-DEC-2006). Unspecified medical attention was sought. Additional information has been requested. No further information is available.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Diarrhoea
Clinical narrative: Information has been received from a physician concerning a 2 month old female who on 13-MAR-2007 was vaccinated with a 2 mL PO dose of Rotateq. Concomitant vaccination administered that day a dose of included Pediarix, a dose of Prevnar and a dose of Hib (manufacturer unknown). On 15-MAR-2007 the patient developed severe diarrhea two days after vaccination. The patient was taken to the emergency room. Subsequently, the patient recovered. The patient's severe diarrhea was considered to be an other important medical event. Additional information has been requested.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Diarrhoea, Irritability, Vomiting
Clinical narrative: Information has been received from a physician concerning a 10 week old male, with reflux issues, who on 15-MAR-2007was vaccinated with the oral first dose of Rotateq (Lot# 655485/1033F). Concomitant vaccines administered on the same day included an intramuscular first dose in the left thigh of PEDIARIX (Lot# AC21B079BA), a first intramuscular dose in the right thigh of PEDVAXHIB (Lot# 653301/0278F), a first intramuscular dose in the right thigh of PREVNAR (Lot# B08674B). Concomitant therapy also included REGLAN, ZANTAC, and DIFLUCAN. On the morning of 21-MAR-2007 the patient experienced diarrhea, about seven to eight times, and in the afternoon experienced vomiting, about four or five times. It was noted that the child was a little fussy according to the patient's mother. The patient's vomiting and diarrhea were gone by 23-MAR-2007, and the patient was noted to be recovered. There were no laboratory or diagnostic test performed. Unspecified medical attention was sought. No product quality complaint was involved. Additional information is not expected.
Age: 2.0
Sex: M
Vaccine: RV5
Symptoms: Abnormal faeces, Diarrhoea, Exposure to vaccinated person, Secondary transmission, Vomiting
Clinical narrative: Information has been received from a physician's nurse concerning a 2 year old male who's 2 month old brother was vaccinated with an oral dose of rotavirus on 02-MAR-2007. One week later, on 09-MAR-2007, the 2 year old experienced developed vomiting and diarrhea. It was reported that the patient's mother believed that the patient had rotavirus. It was noted that the patient was not immunocompromised. The patient's mother said that the "stools smelled like rotavirus." The physician did not diagnose the patient with rotavirus since he was not brought into the office until three days after the symptoms had started. No product quality complaint was involved. No other information was provided. Additional information has been requested.  This is in follow-up to report(s) previously submitted on 4/13/2007.  Information has been received from a physician's nurse concerning a 23 month old male who's 2 month old brother was vaccinated with an oral first dose of ROTATEQ (Lot# 655867/1111F) on 02-MAR-2007.  One week later, on 09-MAR-2007, the 2 year old experienced developed vomiting and diarrhea.  It was reported that the patient's mother believed that the patient had rotavirus.  It was noted that the patient was not immunocompromised.  The patient's mother said that the "stools smelled like rotavirus."  The physician did not diagnose the patient with rotavirus since he was not brought into the office until three days after the symptoms had started.  There were no laboratory or diagnostic tests performed.  No product quality complaint was involved.  No other information was provided.  Follow-up information indicated that the patient had rotavirus, five times, starting seven days after the patient's sibling received ROTATEQ.  It was reported that the patient recovered.  Additional information is not expected.
Age: 0.17
Sex: U
Vaccine: RV5
Symptoms: Erythema, Rash generalised
Clinical narrative: Information has been received from a physician concerning a 2-month-old patient who on approximately 23-JAN-2007 was vaccinated PO with the first dose of Rotateq. There was no concomitant therapy. The physician reported that on approximately 23-JAN-2007, immediately after the first dose, the patient "turned red" and developed a rash over most of their body. Unspecified medical attention was sought. The patient subsequently recovered. The physician noted that the patient would not receive the second dose of Rotateq. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Hypotonia, Rash
Clinical narrative: Information has been received from a physician concerning a baby who was vaccinated with a first oral dose of Rotateq. It was reported that the baby had a rash and went "limped" right after administration of Rotateq. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information is not expected.
Age: 0.17
Sex: M
Vaccine: RV5
Symptoms: Abdominal pain, Diarrhoea, Muscle spasms
Clinical narrative: Information has been received from a physician concerning an 8 week male who was vaccinated with Rotateq. Subsequently, the patient experienced abdominal pain, cramping and diarrhea for one or two weeks following his two month vaccine dose of Rotateq. The child did not die and needed no medical intervention. Additional information has been requested.
Age: 0.17
Sex: U
Vaccine: RV5
Symptoms: Diarrhoea
Clinical narrative: Information has been received from a physician concerning an approximately 2-month-old patient who was vaccinated PO with a first dose of Rotateq (no lot number provided). Subsequently, within 24 hours of vaccination, the patient experienced diarrhea. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 0.2
Sex: U
Vaccine: RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Information has been received from a licensed practical nurse concerning 11 week patient who on 16-MAR-2007 (twelve days ago) was vaccinated with the first dose of Rotateq (Lot # 656191/1365F). On 28-MAR-2007 the patient experienced inadvertently vaccinated with second dose of Rotateq (Lot # 656191/1365F).
Sex: U
Vaccine: RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with oral 2ml Rotateq. Subsequently, the patient experienced patient received a second dose of rotateq early. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: RV5
Symptoms: Inappropriate schedule of drug administration, Medication error, No adverse effect
Clinical narrative: Information has been received from a health professional concerning a 12-month-old male who on 28-MAR-2007 was vaccinated PO with the first dose of Rotateq. Unspecified medical attention was sought. No problems were reported. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Information has been received from a health professional concerning a patient who was vaccinated with Rotateq. The nurse reported that the patient received the second dose of Rotateq 2 weeks after the first dose. Additional information has been requested. This is in follow-up to report (s) previously submitted on 4/13/2007.  Follow up information has been received from a health professional who reported that no adverse event has been reported.."the mother of the child was only concerned that the vaccine was given within two weeks of the first dose.  Additional information is not expected.
Age: 0.17
Sex: U
Vaccine: RV5
Symptoms: Diarrhoea, Pyrexia, Vomiting
Clinical narrative: Information has been received from a health professional concerning an approximately 6-week-old patient who was vaccinated PO with the first dose of Rotateq. It was reported that the patient subsequently developed vomiting, diarrhea and fever. Unspecified medical attention was sought. It was not certain if the patient's events were related to Rotateq because the patient was sick with acute gastroenteritis at the time of vaccination. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 0.33
Sex: U
Vaccine: RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 16-week-old patient who was vaccinated with the first dose of Rotateq. It was unknown if medical attention was sought. Additional information has been requested.
Age: 0.3
Sex: M
Vaccine: HEP, HIBV, RV5
Symptoms: Body temperature normal, Gastrointestinal sounds abnormal, Haematocrit decreased, Inappropriate schedule of drug administration, Mucous stools
Clinical narrative: Information has been received from a physician concerning a 16 week old male with no known drug reactions or allergies who on 06-FEB-2007 was vaccinated with the first oral dose of Rotateq (Lot# 654664/0726F). Concomitant vaccinations included Hib (unspecified carrier) and hepatitis B (unspecified). On the physician reported that on 09-FEB-2007 (he also reported the onset as two days after vaccination), the patient experienced vomiting 3 times and mucous in stool. The patient went to the emergency room but it was unknown whether the patient was admitted into the hospital. On 12-FEB-2007, the patient recovered from vomiting 3 times. It is  unknown whether the patient will receive the second and third dose of Rotateq. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 4/13/2007.  Information has been received from a physician concerning a 16 week old male with no known drug reactions or allergies who on 06-FEB-2007 was vaccinated with the first oral dose of Rotateq (Lot# 654664/0726F).  There was no illness at the time of vaccination.  Concomitant vaccinations included the first dose of ACTHIB, (Lot # L20306-2) on 06-FEB-2007 IM in the right arm, the first dose of IPOL, (Lot # L20306-2) in left arm and DAPTACEL, (Lot # L01813BA) in left arm both given on 22-JAN-2007.  On the physician reported that on 09-FEB-2007 at 11:45, the patient experienced vomiting 3 times and mucous in stool.  The patient went to the emergency room.  The patient's temperature was 97.4, respirations 22, pulse 20, weight 12 pounds and 12 ounces, and Hematocrit 24.  The patients physical exam was abnormal increased bowel sounds were noted.  The physician's impression was "AGa".  On 12-FEB-2007, the patient recovered from vomiting 3 times.  The patient's weight at the time of the report was 13.5.  It is unknown whether the patient will receive the second and third dose of ROTATEQ.  Additional information has been requested.
Age: 0.3
Sex: M
Vaccine: HEP, HIBV, RV5
Symptoms: Vomiting
Clinical narrative: Information has been received from a physician concerning a 16 week old male with no known drug reactions or allergies who on 06-FEB-2007 was vaccinated with the first oral dose of Rotateq (Lot# 654664/0726F). Concomitant vaccinations included Hib (unspecified carrier) and hepatitis B (unspecified). On the physician reported that on 09-FEB-2007 (he also reported the onset as two days after vaccination), the patient experienced vomiting 3 times and mucous in stool. The patient went to the emergency room but it was unknown whether the patient was admitted into the hospital. On 12-FEB-2007, the patient recovered from vomiting 3 times. It is  unknown whether the patient will receive the second and third dose of Rotateq. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 4/13/2007.  Information has been received from a physician concerning a 16 week old male with no known drug reactions or allergies who on 06-FEB-2007 was vaccinated with the first oral dose of Rotateq (Lot# 654664/0726F).  There was no illness at the time of vaccination.  Concomitant vaccinations included the first dose of ACTHIB, (Lot # L20306-2) on 06-FEB-2007 IM in the right arm, the first dose of IPOL, (Lot # L20306-2) in left arm and DAPTACEL, (Lot # L01813BA) in left arm both given on 22-JAN-2007.  On the physician reported that on 09-FEB-2007 at 11:45, the patient experienced vomiting 3 times and mucous in stool.  The patient went to the emergency room.  The patient's temperature was 97.4, respirations 22, pulse 20, weight 12 pounds and 12 ounces, and Hematocrit 24.  The patients physical exam was abnormal increased bowel sounds were noted.  The physician's impression was "AGa".  On 12-FEB-2007, the patient recovered from vomiting 3 times.  The patient's weight at the time of the report was 13.5.  It is unknown whether the patient will receive the second and third dose of ROTATEQ.  Additional information has been requested.
Age: 0.33
Sex: U
Vaccine: RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Information has been received from a physician concerning a 16 week old twin (sex not reported) who on 06-MAR-2007 was vaccinated orally with the first dose Rotateq. At four months of age the child received the first dose of Rotateq. No further information is available.  Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Cyanosis, Oxygen supplementation
Clinical narrative: Information has been received from a licensed practical nurse concerning a patient who was vaccinated with a dose of Rotateq. Subsequently the patient turned blue and was administered oxygen. Additional information has been requested.
Age: 46.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Myalgia, Paraesthesia, Pyrexia, Urticaria
Clinical narrative: Fever, chills with rigors, myalgias, large welt left upper arm (deltoid) extending down into axilla and halfway down left upper arm, paresthesias left upper arm.
Age: 0.58
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Myoclonus, Pyrexia
Clinical narrative: Myoclonic jerks with fever approx 102 lasted about 1 hour. Neurologist evaluated and felt might be from vaccine
Age: 83.0
Sex: F
Vaccine: PPV
Symptoms: Contusion, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Pneumovax on 4-4-07- On 4-5-07-pain at injection site down right arm- 4-6-07- Redness and mild swelling. Shoulder bruise with red redness to mid-forearm- Benadryl cream-cold packs
Age: 55.0
Sex: M
Vaccine: PPV
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: nausea, fever (not measured by patient), muscle aches for 2 days after Pneumovax given 3/14 07
Age: 23.0
Sex: F
Vaccine: RAB
Symptoms: Erythema, Feeling hot, Injection site erythema, Injection site warmth, Nausea
Clinical narrative: Client Stated redness from left deltoid to wrist, warm to touch, warm sensation all over, and nausea symptoms happened within 4 hours of shot after client went back to work. client toke Benadryl PO and had someone call us with information on reaction. Spoke with client and had her come into the clinic. The L arm was warm and pink from the shoulder to above the wrist.
Age: 23.0
Sex: F
Vaccine: RAB
Symptoms: Skin warm
Clinical narrative: Client Stated redness from left deltoid to wrist, warm to touch, warm sensation all over, and nausea symptoms happened within 4 hours of shot after client went back to work. client toke Benadryl PO and had someone call us with information on reaction. Spoke with client and had her come into the clinic. The L arm was warm and pink from the shoulder to above the wrist.
Age: 1.66
Sex: M
Vaccine: DTAP
Symptoms: Blister, Rash papular, Scab
Clinical narrative: Papules, blister and scab, trunk, face and some on extremities
Age: 1.21
Sex: M
Vaccine: DTAPH, HEPA
Symptoms: Chest X-ray normal, Convulsion, Electrocardiogram normal, Eye rolling, Fall
Clinical narrative: Rec'd vaccines at routine well check. On 4-6-07 was at day care. Worker heard a fall, did not witness so unsure if she fell and then had seizure, or if seizure/syncope caused fall. She was unconscious, eyes rolled back, fist clenched then moving (flexing) rhythmically at wrists/elbows. Duration 10" before regain consciousness.
Age: 1.21
Sex: M
Vaccine: DTAPH, HEPA
Symptoms: Full blood count, Loss of consciousness, Reflexes abnormal, Syncope
Clinical narrative: Rec'd vaccines at routine well check. On 4-6-07 was at day care. Worker heard a fall, did not witness so unsure if she fell and then had seizure, or if seizure/syncope caused fall. She was unconscious, eyes rolled back, fist clenched then moving (flexing) rhythmically at wrists/elbows. Duration 10" before regain consciousness.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site rash, Injection site urticaria
Clinical narrative: Patient was given the vaccine and within 5 minutes she showed me a rash on her arm with a welt at site given. She was given a dose of Benadryl and watched for 15 minutes.
Age: 0.38
Sex: M
Vaccine: HIBV
Symptoms: Crying
Clinical narrative: On 4-11-07 mother stated child cried a lot after Hib on 4-4-07
Age: 1.45
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Medication error, Wrong drug administered
Clinical narrative: Ordered to received Dtap #4. Was given Pediarix, Polio and Hep B vaccinations were up to date. Required no medical treatment.
Age: 0.35
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Pyrexia
Clinical narrative: Evening time - infant developed fever Tm 104 - given Tylenol at home.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema
Clinical narrative: Local reaction - Red, raised 5x5 cm
Age: 5.0
Sex: M
Vaccine: IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site oedema, Injection site pain, Injection site swelling
Clinical narrative: Rt lower thigh Swelling, redness, slight pain x 2d. Central darker red very slightly edematous 2 cm diameter larger 5 cm faint red circle
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Swelling
Clinical narrative: Redness and swelling not warm to touch pt on Abx for strep right arm
Age: 1.51
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Pt presented with rash on torso and back starting less than 24 hour ago.
Age: 28.0
Sex: F
Vaccine: TYP
Symptoms: Body temperature increased, Headache, Nausea
Clinical narrative: Severe nausea, Headache, slight temperature elevation
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Body temperature increased, Dizziness, Influenza, Nausea
Clinical narrative: Client called to report nausea and dizzines noted 4/13/07 after receiving Tdap vaccine 4/12/07.  Client states she attributes symptoms to the "flu" as several coworkers have come down with it.  Denies other symptoms.  Temp 99.2
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: Patient had PPD and Varicella vaccine (dose #2) administered on 4/13.  Patient's mother reports that there was visible redness on the afternoon of 4/13 at the site of both injections.  Swelling and pain noted at the sights on 4/14.  Seen by MD on Sunday, 4/15.  Left arm (site of varicella booster) had 17x12 cm area of erythema, with 6.5cm round, firm induration assoc. with discomfort.  Left forarm with 3cm round area of erythema at site of PPD.  .5cm round induration.
Age: 12.0
Sex: M
Vaccine: HEPA, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: PT RECIEVED VARICELLA VACCINTATION IN LLA. UPON RECIEVING INJECTION PT STARTED TO C/O ITCHING AT THE SITE. UPON INSPECTION THE PT APPEARED TO HAVE A SIGNIFICANT OF REDNESS AND SWELLING. PT STATED HE WAS NOT HAVING ANY DIFFICULTIES BREATHING OF AGITATION JUST ITCHING. PT WAS ASKED TO STAY AT CLINIC FOR OBSERVATION. AFTER PERIODIC EVALUATION OF PT REDNESS AND SWELLING WERE SUBSIDING, PT HAD NO C/O OF DIFFICULTY BREATHING. PT FATHER WAS ADVISED TO GIVE THE PT SOME BENADRYL AND WATCH IT CLOSELY, HE WAS ALSO GIVEN A PHONE NUMBER IF HE NEEDED ANYTHING. BEFOR LEAVING THE CLINIC THE PT REDNESS HAD DECREASED TO A QUARTER SIZE SPOT AT THE INJECTION SITE WITH NO FURTHER SWELLING OR C/O ITHCING. PT FATHER WS PHONED AFTER RETURNING TO CLINIC AT 5:30 PM, HE STATED THAT THE PT WAS NO LONGER HAVING ANY PROBLEMS WITH THE SITE OF DIFFICULTY BREATHING.
Age: 17.0
Sex: F
Vaccine: HPVX, MMR, MNQ
Symptoms: Convulsion, Eye rolling, Musculoskeletal stiffness, Screaming, Syncope
Clinical narrative: Sindy fainted and had a convulsion/seizure immediately after receiving the first HPV shot. While she was out, she suddenly lifted her upper body, rolled her eyes, made a screeching noise (like scared) and stiffed her hands.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site bruising, Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: On 4/11/07 Client came to Immunization Clinic for Routine 4y/o vaccinations.  Mom states that day did not seem to have ill effcts, just a small bruise at the area of the shot.  The next day Mom noted redness approx. size of 2" on the right leg where the DTaP had been given.  On Friday 4/13/07 Mom noted in the AM that the redness had increased to approx. 4" and she then made an appointment for the child to see his Family Physician for that afternoon.  His appointment was at 2:45 PM and by that time the redness had gone around his entire upper thigh.  He complained of itching at this time and it was "very red slightly swollen and "hot" to touch.  Mom staes he was examined by Dr. and was given a Rocephin injection (she did not know the dose he was given).  He was also given a presciption for Omnicef 250mg/ml 6ml daily for 10 days, which he is presently taking.  When questioned Mom on his condition following his appointment, she stated that by 4/14/07, the redness was gone and he wasn't complaining of any other symtoms.
Age: 0.58
Sex: M
Vaccine: DTAPHEPBIP, PNC
Symptoms: Respiratory rate increased, Urticaria, Vomiting
Clinical narrative: hives, within 15 minutes of receiving vaccine.  vomited once, within 30 minutes.  notified physician, who said to give benedryl.  gave and then took to physician office and was seen by nurse pract.  gavin was better by time arrived at physician office.  still increased respiration.  NP stated no way to know if reaction to vaccine.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Abnormal behaviour, Speech disorder, Speech disorder developmental
Clinical narrative: july, 2006, began regressing in speech, and did not want anything to do with family and friends.  mom states big for age.  does not talk a lot and vocabulary has decreased to 10 - 15 words.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity, Physiotherapy, Tendonitis
Clinical narrative: Patient with onset of significant pain in arm in the day following her immunization, mainly at night, worse with movement.  Discussed 2/15/07, pain still "exteme", but slowly improving.  Seen 4/12/2007 and diagnosed with tendonitis.  Patient currently undergoing physical therapy.
Age: 13.0
Sex: F
Vaccine: HEPA
Symptoms: Urticaria
Clinical narrative: Developed hives all over body approx 2 hours after vaccine administration
Age: 40.0
Sex: F
Vaccine: PPV
Symptoms: Asthenia, Chills, Headache, Influenza like illness, Insomnia
Clinical narrative: Fever, extreme persistent throbbing pain in shoulder and arm where the injuction was administered, chills and flulike sypmtoms, soaking night sweats, and severe headache (2 days in duration).  The throbbing in the arm was so severe that sleep was not possible, this resolved in 18 hours, the arm remained moderately sore for an additional 2 days.  General body weakness has persisted.
Age: 40.0
Sex: F
Vaccine: PPV
Symptoms: Lymphocyte count decreased, Musculoskeletal pain, Night sweats, Pain in extremity, Pyrexia
Clinical narrative: Fever, extreme persistent throbbing pain in shoulder and arm where the injuction was administered, chills and flulike sypmtoms, soaking night sweats, and severe headache (2 days in duration).  The throbbing in the arm was so severe that sleep was not possible, this resolved in 18 hours, the arm remained moderately sore for an additional 2 days.  General body weakness has persisted.
Age: 40.0
Sex: F
Vaccine: PPV
Symptoms: Red blood cell count normal, White blood cell count normal
Clinical narrative: Fever, extreme persistent throbbing pain in shoulder and arm where the injuction was administered, chills and flulike sypmtoms, soaking night sweats, and severe headache (2 days in duration).  The throbbing in the arm was so severe that sleep was not possible, this resolved in 18 hours, the arm remained moderately sore for an additional 2 days.  General body weakness has persisted.
Age: 2.0
Sex: F
Vaccine: HEPA
Symptoms: Pyrexia, Rash
Clinical narrative: onset of rash on face, trunk & genitalia approximately 20 hours after receiving Hep A #2 with low-grade fever (100F), now resolved. Symptoms have essentially resolved at this time. No treatment required.
Age: 40.0
Sex: M
Vaccine: ANTH
Symptoms: Musculoskeletal stiffness
Clinical narrative: Stiffness in elbow of arm (left)in which I received the immunization.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Abnormal behaviour, Lethargy, Pyrexia
Clinical narrative: Pt s mom notice that child was extremely lethargic running a fever of 100.0 child just not himself
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Cellulitis, Injection site rash, Injection site vesicles
Clinical narrative: Developed cellulitis/rash at injection site on left thigh with some blistering.  Seen at acute care center day after vaccines given and given keflex; then seen at our office the next day for continued spread and given ceftriaxone with resolution of the rash over the next 2 days.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Pain, Pyrexia, Rash
Clinical narrative: I received Zostavax Vaccine on 3/23/07.  My wife started having pain on Monday 3/26/07 by 3/28/07 she was running a fever over 101 & started to get a rash.  The fever lasted approximately 2 days and the rash continued to expand and blister.  She saw her Doctor on Monday 4/3/07.  He said she had shingles and gave her Famvir 500mg and Propo-N/APAP 100-650 Tab.  She has since returned to see the physician 2 times for symptoms.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Secondary transmission
Clinical narrative: I received Zostavax Vaccine on 3/23/07.  My wife started having pain on Monday 3/26/07 by 3/28/07 she was running a fever over 101 & started to get a rash.  The fever lasted approximately 2 days and the rash continued to expand and blister.  She saw her Doctor on Monday 4/3/07.  He said she had shingles and gave her Famvir 500mg and Propo-N/APAP 100-650 Tab.  She has since returned to see the physician 2 times for symptoms.
Age: 14.0
Sex: F
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Antinuclear antibody, Arthralgia, Aspiration joint, Blood creatine phosphokinase, Culture
Clinical narrative: 4/6/07 - woke up morning with left knee pain/swelling Advil, 4/7/07 - seen at walk in clinic _ CPK normal Advil continued, 4/9/07 L Knee pain, seen another MD - Osgood Schlater, 4/10/07 L knee pain/swelling - seen another MD - arthralgia - Prednisone, 4/13/04 R knee swelling Hosp ER admitted. 1/1/10 follow up - continues to have pain in knees during sports activity and stiffness and aching when sitting for long periods of time.
Age: 14.0
Sex: F
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Joint swelling, Osteochondrosis, Osteosclerosis
Clinical narrative: 4/6/07 - woke up morning with left knee pain/swelling Advil, 4/7/07 - seen at walk in clinic _ CPK normal Advil continued, 4/9/07 L Knee pain, seen another MD - Osgood Schlater, 4/10/07 L knee pain/swelling - seen another MD - arthralgia - Prednisone, 4/13/04 R knee swelling Hosp ER admitted. 1/1/10 follow up - continues to have pain in knees during sports activity and stiffness and aching when sitting for long periods of time.
Age: 14.0
Sex: F
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Arthralgia, Aspiration joint, Blood test, Gait disturbance, Inflammation
Clinical narrative: 4/6/07 - woke up morning with left knee pain/swelling Advil, 4/7/07 - seen at walk in clinic _ CPK normal Advil continued, 4/9/07 L Knee pain, seen another MD - Osgood Schlater, 4/10/07 L knee pain/swelling - seen another MD - arthralgia - Prednisone, 4/13/04 R knee swelling Hosp ER admitted. 1/1/10 follow up - continues to have pain in knees during sports activity and stiffness and aching when sitting for long periods of time.
Age: 14.0
Sex: F
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Joint effusion, Joint swelling, Juvenile arthritis, Musculoskeletal pain, Pain in extremity
Clinical narrative: 4/6/07 - woke up morning with left knee pain/swelling Advil, 4/7/07 - seen at walk in clinic _ CPK normal Advil continued, 4/9/07 L Knee pain, seen another MD - Osgood Schlater, 4/10/07 L knee pain/swelling - seen another MD - arthralgia - Prednisone, 4/13/04 R knee swelling Hosp ER admitted. 1/1/10 follow up - continues to have pain in knees during sports activity and stiffness and aching when sitting for long periods of time.
Age: 14.0
Sex: F
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Tendonitis
Clinical narrative: 4/6/07 - woke up morning with left knee pain/swelling Advil, 4/7/07 - seen at walk in clinic _ CPK normal Advil continued, 4/9/07 L Knee pain, seen another MD - Osgood Schlater, 4/10/07 L knee pain/swelling - seen another MD - arthralgia - Prednisone, 4/13/04 R knee swelling Hosp ER admitted. 1/1/10 follow up - continues to have pain in knees during sports activity and stiffness and aching when sitting for long periods of time.
Age: 0.34
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Atrial tachycardia, Blood culture negative, Blood glucose increased, Blood potassium increased, Blood sodium normal
Clinical narrative: Pt well at time of administration of immunizations. Began vomiting approx 4 hrs after imm. given, then not feeding well, then became somewhat irritable. Taken to ER by parents about 14 hrs after imm. given. No fever. Diagnosed with Paroxysmal atrial tachycardia, and shock. Adenosine IV administered in ER as directed per Ped cardiologist. Transported via air to medical center. 4/20/07 Received med record for 4/13/07 which includes vax lot numbers which confirms VAERS report.  5/25/07 Received hospital medical records which reveal patient experienced SVT unresponsive to treatment & multiple bouts of emesis prior to being seen at outlying facility.  Blood c/s done & given IV antibiotics prior to transfer.  On admit, heart rate was 210-217 & was hypothermic w/poor perfusion.  He was grunting w/O2 sats of 85 & was started on O2 & then intubated for unstable cardiac condition.  Multiple cardiac meds & multiple cardioversions were done before he was able to be converted to NSR.  ID consult did not feel SVT was due to pertussis vaccine & continued on IV antibiotics.  Was transferred again to higher level of care.  6/8/07 Received 3rd hospital medical records which reveal patient admitted 4/15-4/19/07 to peds cardiology ICU.  Prior to admit, patient experienced increased sleepiness & persistent vomiting.  Seen at outlying ER & PICU & found to have wide complex tachycardia resistant to multiple drug therapies.  Intubated.  Attempts at cardioversion were unsuccessful.  Rhythm slowed decreased s/p sodium bicarb & was started on esmolol & transferred to another hospital.  Able to be successfully extubated day after admission & weaned to RA.  Was in same rhythm but able to be successfully converted with meds.  Remained in stable condition, diet advanced & changed to oral meds.  D/C to home on propranolol  FINAL DX: Supraventricular tachycardia & atrial septal defect.  1/1/10 follow up - after the episode reported above, patient was diagnosed by ped. cardiologist with junctional ectopic tachycardia. he is controlled with amiodarone. he has had additional tachycardia episodes but none related to further immunizations- he has been kept current on his immunizations.
Age: 0.34
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Carbon dioxide decreased, Chest X-ray normal, Feeding disorder neonatal, Irritability, Shock
Clinical narrative: Pt well at time of administration of immunizations. Began vomiting approx 4 hrs after imm. given, then not feeding well, then became somewhat irritable. Taken to ER by parents about 14 hrs after imm. given. No fever. Diagnosed with Paroxysmal atrial tachycardia, and shock. Adenosine IV administered in ER as directed per Ped cardiologist. Transported via air to medical center. 4/20/07 Received med record for 4/13/07 which includes vax lot numbers which confirms VAERS report.  5/25/07 Received hospital medical records which reveal patient experienced SVT unresponsive to treatment & multiple bouts of emesis prior to being seen at outlying facility.  Blood c/s done & given IV antibiotics prior to transfer.  On admit, heart rate was 210-217 & was hypothermic w/poor perfusion.  He was grunting w/O2 sats of 85 & was started on O2 & then intubated for unstable cardiac condition.  Multiple cardiac meds & multiple cardioversions were done before he was able to be converted to NSR.  ID consult did not feel SVT was due to pertussis vaccine & continued on IV antibiotics.  Was transferred again to higher level of care.  6/8/07 Received 3rd hospital medical records which reveal patient admitted 4/15-4/19/07 to peds cardiology ICU.  Prior to admit, patient experienced increased sleepiness & persistent vomiting.  Seen at outlying ER & PICU & found to have wide complex tachycardia resistant to multiple drug therapies.  Intubated.  Attempts at cardioversion were unsuccessful.  Rhythm slowed decreased s/p sodium bicarb & was started on esmolol & transferred to another hospital.  Able to be successfully extubated day after admission & weaned to RA.  Was in same rhythm but able to be successfully converted with meds.  Remained in stable condition, diet advanced & changed to oral meds.  D/C to home on propranolol  FINAL DX: Supraventricular tachycardia & atrial septal defect.  1/1/10 follow up - after the episode reported above, patient was diagnosed by ped. cardiologist with junctional ectopic tachycardia. he is controlled with amiodarone. he has had additional tachycardia episodes but none related to further immunizations- he has been kept current on his immunizations.
Age: 0.34
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Vomiting, White blood cell count increased
Clinical narrative: Pt well at time of administration of immunizations. Began vomiting approx 4 hrs after imm. given, then not feeding well, then became somewhat irritable. Taken to ER by parents about 14 hrs after imm. given. No fever. Diagnosed with Paroxysmal atrial tachycardia, and shock. Adenosine IV administered in ER as directed per Ped cardiologist. Transported via air to medical center. 4/20/07 Received med record for 4/13/07 which includes vax lot numbers which confirms VAERS report.  5/25/07 Received hospital medical records which reveal patient experienced SVT unresponsive to treatment & multiple bouts of emesis prior to being seen at outlying facility.  Blood c/s done & given IV antibiotics prior to transfer.  On admit, heart rate was 210-217 & was hypothermic w/poor perfusion.  He was grunting w/O2 sats of 85 & was started on O2 & then intubated for unstable cardiac condition.  Multiple cardiac meds & multiple cardioversions were done before he was able to be converted to NSR.  ID consult did not feel SVT was due to pertussis vaccine & continued on IV antibiotics.  Was transferred again to higher level of care.  6/8/07 Received 3rd hospital medical records which reveal patient admitted 4/15-4/19/07 to peds cardiology ICU.  Prior to admit, patient experienced increased sleepiness & persistent vomiting.  Seen at outlying ER & PICU & found to have wide complex tachycardia resistant to multiple drug therapies.  Intubated.  Attempts at cardioversion were unsuccessful.  Rhythm slowed decreased s/p sodium bicarb & was started on esmolol & transferred to another hospital.  Able to be successfully extubated day after admission & weaned to RA.  Was in same rhythm but able to be successfully converted with meds.  Remained in stable condition, diet advanced & changed to oral meds.  D/C to home on propranolol  FINAL DX: Supraventricular tachycardia & atrial septal defect.  1/1/10 follow up - after the episode reported above, patient was diagnosed by ped. cardiologist with junctional ectopic tachycardia. he is controlled with amiodarone. he has had additional tachycardia episodes but none related to further immunizations- he has been kept current on his immunizations.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, RV5, RV5
Symptoms: Surgery
Clinical narrative: 1/12/07 - Received Rotavirus vaccine. Surgery for intussusception 4/2007.  5/18/07 Received medical records from hospital which reveal patient experienced 1 day history of vomiting, retching, fever, bloody stools.  Abdomen was soft but tender in RUQ.  Admitted 4/8-4/9/07.  Unable to reduce completely & taken to OR for laproscopy reduction of intussusception & appendectomy.  Findings at surgery were 10cm of small bowel invaginated into cecumProgressed well post operatively & d/c to home next day to f/u in clinic.  FINAL DX: Intestinal intussusception, surgically reduced./ss 5/25/07 Received medical records from PCP but vax records not included.  T/C to PCPs copy service to request vax records/lot #s.  States will mail to me.  7/3/07 T/C to PCP to check status of request.  States unable to print info to include lot #.  States info on VAERS report is correct.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, RV5, RV5
Symptoms: Intussusception, Surgery
Clinical narrative: 1/12/07 - Received Rotavirus vaccine. Surgery for intussusception 4/2007.  5/18/07 Received medical records from hospital which reveal patient experienced 1 day history of vomiting, retching, fever, bloody stools.  Abdomen was soft but tender in RUQ.  Admitted 4/8-4/9/07.  Unable to reduce completely & taken to OR for laproscopy reduction of intussusception & appendectomy.  Findings at surgery were 10cm of small bowel invaginated into cecumProgressed well post operatively & d/c to home next day to f/u in clinic.  FINAL DX: Intestinal intussusception, surgically reduced./ss 5/25/07 Received medical records from PCP but vax records not included.  T/C to PCPs copy service to request vax records/lot #s.  States will mail to me.  7/3/07 T/C to PCP to check status of request.  States unable to print info to include lot #.  States info on VAERS report is correct.
Age: 71.0
Sex: F
Vaccine: MNQ
Symptoms: Asthenia, CSF cell count, CSF glucose normal, Epstein-Barr virus test positive, Guillain-Barre syndrome
Clinical narrative: Patient diagnosed with Autoimmune Hemolytic Anemia in September 2006 complicated by EBV infection. Received vaccine prior to Splenectomy on 1-29-07. On 3-17-07 started having progressive weakness consistent with Guillan Barre Syndrome. 7/25/07-records received for DOS 3/27-4/18/07- DC DX: Guillain-Barre syndrome. Respiratory failure secondary to Guillain-Barre syndrome. Urinary tract infection. Autoimmune hemolytic anemia. Diabetes mellitus. Seen in ER with C/O low blood pressure 82/40. C/O profound weakness and dizziness for past few day. No fever, no chills no nausea, no vomiting, no diarrhea, no chest pain, no shortness of breath.  Treated with IVIG. Transferred to rehabilitation facility. 1/4/10 The patient was subsequently diagnosed with Angiaimmunodible T cell lymphormin with continued deterioration.